NCT02620566

Brief Summary

To our knowledge there is still no study comparing the local wound infiltration by itself without ilio-inguinal and ilio-hypogastric nerve block and caudal anesthesia. The aim of this study was to evaluate anesthesia and recovery profile in pediatric patients after inguinal hernia repair with caudal block (CB) or local wound infiltration (LWI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Sep 2015

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

September 20, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 3, 2015

Completed
Last Updated

January 5, 2016

Status Verified

January 1, 2016

Enrollment Period

3 months

First QC Date

September 20, 2015

Last Update Submit

January 3, 2016

Conditions

Keywords

caudal blocklocal wound infiltrationhernia repair

Outcome Measures

Primary Outcomes (1)

  • Time to First Analgesic Requirement

    The time to first supplemental oral acetaminophen demand (first acetaminophen time) was defined as the time from the end of surgery to the first registration of more than 4 on both CHEOPS and FLACC by the investigator. At t0. 30 min postoperative; t1 1h postoperative; t2 2h postoperative; t3 3h posoperative; t4 6h posoperative; t5 12h posoperative; t6 24h postoperative

    24 hours

Secondary Outcomes (1)

  • The total number of oral acetaminophen

    The number of analgesic received for the period of 24 hours

Other Outcomes (2)

  • Postoperative Pain

    30 minutes postoperative, 1 hour postoperative, 2 hour postoperative, 3 hour postoperative, 6 hour postoperative , 12 hours postoperative, 24 post operative

  • Motor block

    30 minutes postoperative, 1 hour postoperative, 2 hour postoperative, 3 hour postoperative, 6 hour postoperative , 12 hours postoperative, 24 post operative

Study Arms (2)

Bupivacain -Caudal

ACTIVE COMPARATOR

Single shot Caudal Block will receive Group C with 1ml per kg Bupivacain 0,25%.

Procedure: Bupivacain- Caudal

Bupivacain- Local

ACTIVE COMPARATOR

Single shot Local Infiltration will receive Group L with 0,2ml per kg Bupivacain 0,25%.

Procedure: Bupivacaine- Local

Interventions

Bupivacain for caudal blocks, Group C received 1 ml kg of 0.25% (maximum volume 20 ml).

Also known as: Caudal block
Bupivacain -Caudal

Bupivacain for Local Wound Infiltration Group L received 0,2 ml kg 0,25% (maximum volume 4 ml).

Also known as: Local Wound Infiltration
Bupivacain- Local

Eligibility Criteria

Age6 Months - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • month to 7 years
  • ASA physical status I or II
  • undergoing unilateral hernia repair

You may not qualify if:

  • history of developmental delay or mental retardation
  • type I diabetes
  • known or suspected coagulopathy
  • known allergy to any local anesthetic
  • known congenital anomaly of the spine
  • signs of spinal anomaly or infection at the sacral or inguinal region

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uctoariced

Skopje, 1000, North Macedonia

Location

Study Officials

  • Aleksandra Gavrilovska-Brzanov, MD. Msc

    Mother Theresa University Clinical Center Skopje Macedonia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 20, 2015

First Posted

December 3, 2015

Study Start

September 1, 2015

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

January 5, 2016

Record last verified: 2016-01

Locations